ACTA1 and kidney disorder: Accumulating evidence on kidney diseases suggests that ILK ablation in vivo diminishes the expression of the EMT marker α-smooth muscle actin (α-SMA) and the inducer TGF-β1 in renal tubular epithelial cells in a model of cisplatin-induced acute kidney injury [59–61].